Spotlight
Video

MONALEESA-3 study in HR+/HER2- advanced breast cancer

obr has 860 videos Subscribe Here

Loading........
Description: Douglas W. Blayney, MD, Professor of Medicine, Associate Division Chief of Medical Oncology, Stanford Healthcare, on the significant improvement in PFS in the fulvestrant + ribociclib arm of the MONALEESA-3 study in HR+/HER2- advanced breast cancer.
Shared By : obr
Posted on : 07/27/18
Added : 12 months ago
Category : Breast Cancer